Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
Background & Aims: There have been conflicting reports regarding acid secretion after treatment with omeprazole. This study examined acid secretion after treatment with omeprazole and its relation to Helicobacter pylori status and on-treatment gastric function. Methods: Twelve H. pylori–negative...
Gespeichert in:
Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 1999-02, Vol.116 (2), p.239-247 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background & Aims: There have been conflicting reports regarding acid secretion after treatment with omeprazole. This study examined acid secretion after treatment with omeprazole and its relation to
Helicobacter pylori status and on-treatment gastric function.
Methods: Twelve
H. pylori–negative and 9
H. pylori–positive subjects were examined before, on, and at day 15 after an 8-week course of 40 mg/day omeprazole. On each occasion, plasma gastrin, intragastric pH, and acid output were measured basally and in response to increasing doses of gastrin 17.
Results: In the
H. pylori–negative subjects at day 15 after omeprazole treatment, basal acid output was 82% higher (
P < 0.007) and maximal acid output 28% higher (
P < 0.003) than before omeprazole. The degree of increase in maximal acid output was related to both on-treatment pH and on-treatment fasting gastrin levels, being 48.0% in subjects with an on-treatment pH of >4 vs. 21.0% in those with a pH of 25 ng · L
−1 vs. 19.8% in those with a fasting gastrin of |
---|---|
ISSN: | 0016-5085 1528-0012 |
DOI: | 10.1016/S0016-5085(99)70118-6 |